How is Fujifilm increasing Avigan production?
Fujifilm expects to increase the production of Avigan up to 100,000 treatment courses by July 2020, about 2.5 times more compared to the beginning of March when the company first began its current production run, and then to 300,000 by September, it said in a statement on Wednesday.
Why is Avigan being tested as a COVID-19 treatment?
Fujifilm is allocating additional capacity at its Fujifilm Wako Pure Chemical Co facility in Japan to produce the ingredients used to make Avigan. The company has also made partnerships with domestic and overseas companies for manufacturing processes and the production of raw ingredients. Fujifilm is conducting clinical trials of Avigan on patients of COVID-19 in Japan and the United States. Originally published on www.japantoday.comAlso read: Japanese Toilet Industry May See Surge in Demand Globally · Toyobo Develops Test Kit To Detect Coronavirus Within One Hour · How A Japanese Company Became A Darling Of The Eyewear Industry?






Mizuho To Stop Lending To New Coal Power Projects